Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: debra vogt who wrote (52966)	7/27/1999 11:51:00 AM
From: Long John	Respond to of 120523

Thanks Debra. I would have wondered why they didn't report this week. Add this one to the list of stocks doing well after earnings, with JAKK, HIFN, CMTN. John

To: debra vogt who wrote (52966)	7/27/1999 11:59:00 AM
From: Jerry Olson	Read Replies (1) \| Respond to of 120523

Debra they did???? was it good<g>???? chart says yes...

To: debra vogt who wrote (52966)	7/27/1999 1:03:00 PM
From: debra vogt	Read Replies (1) \| Respond to of 120523

Millennium Pharmaceuticals Added to S&P Midcap 400 Index July 26, 1999 05:43 PM NEW YORK, July 26 /PRNewswire/ -- Standard & Poor's will replace Gulfstream Aerospace (GAC) in the S&P MidCap 400 Index with Millennium Pharmaceuticals (MLNM) after the close of trading on Friday, July 30, 1999. General Dynamics, an S&P 500 component, is acquiring Gulfstream Aerospace in a stock deal anticipated to close on that date. The transaction is still subject to shareholders approval. Millennium Pharmaceuticals is a leading provider of products and services that enhance drug discovery and development efforts of pharmaceutical and biotechnology firms. The company, headquartered in Cambridge, Massachusetts, will be added to the S&P MidCap 400 Biotechnology industry group